Related Articles
Glucose transporter‑1 inhibition overcomes imatinib resistance in gastrointestinal stromal tumor cells
TUFM‑knockdown inhibits the migration and proliferation of gastrointestinal stromal tumor cells
Effects of imatinib vary with the types of KIT-mutation in gastrointestinal stromal tumor cell lines
Proteomic analysis of imatinib-resistant CML-T1 cells reveals calcium homeostasis as a potential therapeutic target
Identification of imatinib‑resistant long non‑coding RNAs in gastrointestinal stromal tumors